<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Disturbances of Growth & Neoplasia | General Pathology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts - Inter for UI, Source Serif for reading -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link for Accessibility -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle (Fixed Position) -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Links will be populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="topic-07-circulatory-disturbances.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">08</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">09</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 88%;"></div>
                            </div>
                            <span class="progress-label">Disturbances of Growth & Neoplasia</span>
                        </div>
                        
                        <a href="topic-08-neoplasia-part2.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Disturbances of Growth & Neoplasia</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">ü¶Ä</span>
                        <span class="badge-text">Section 08</span>
                    </div>
                    <h1 class="document-title">DISTURBANCES OF GROWTH</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üìÑ</span>
                            <span>Neoplasia, Carcinogenesis, Tumors</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">
                    
                    <!-- START: growth-disturbances -->
                    <section id="growth-disturbances" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">General Concepts</h2>
                        </div>
                        
                        <div class="content-card">
                            <h3 id="any-growth-entails">Any growth entails:</h3>
                            <p>Cell proliferation or division with an Increase in number of cells<br>
                            Cell maturation and differentiation is the change in appearance and function<br>
                            Any growth may be:<br>
                            Normal or physiologic (controlled)<br>
                            Abnormal or Pathologic (controlled or uncontrolled)</p>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-d6b8d6ab.jpeg" alt="Growth Disturbances Diagram" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                            </figure>

                            <h4 id="decreased-growth">Decreased growth</h4>
                            <p>A) Developmental or congenital</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Agnesia:</strong> Means complete absence of an organ e.g. absence of a whole kidney.</li>
                                <li class="list-item"><strong>Aplasia:</strong> Means complete failure of cell growth of an organ( severe from of hypoplasia) e.g. a kidney.</li>
                                <li class="list-item"><strong>Hypoplasia:</strong> Means failure to reach full-sized development e.g. infantile uterus.</li>
                            </ul>
                            <p>B) Non Developmental - atrophy (see before)</p>

                            <h4 id="increased-growth">Increased growth</h4>
                            <p>A) Non Neoplastic (adaptations &amp; controlled growths - see before)</p>
                            <ol class="enhanced-list">
                                <li class="list-item">Hypertrophy</li>
                                <li class="list-item">Hyperplasia</li>
                                <li class="list-item">Metaplasia</li>
                                <li class="list-item">Dysplasia</li>
                            </ol>
                            <p>B) Neoplastic (uncontrolled growths or tumours)</p>
                        </div>

                        <div class="content-card">
                            <h3 id="dysplasia">DYSPLASIA (Fig 17)</h3>
                            <p><strong>Definition:</strong> A non neoplastic disordered cellular proliferation, maturation and differentiation of cells usually in association with chronic irritation &amp; chronic inflammation</p>
                            
                            <p><strong>Sites:</strong></p>
                            <ol class="enhanced-list">
                                <li class="list-item">Mucous membranes of the cervix uteri, bronchi, oral cavity, urinary bladder, colon and gall bladder.</li>
                                <li class="list-item">Skin epidermis.</li>
                                <li class="list-item">Liver.</li>
                            </ol>

                            <p><strong>Gross:</strong> Nonspecific gross appearance</p>

                            <p><strong>Microscopic Picture:</strong> is characterized by</p>
                            <ol class="enhanced-list">
                                <li class="list-item">Loss of cell pattern i.e. normal orderly arrangement (polarity) with increase in layers of immature cells</li>
                                <li class="list-item">The dysplastic cells show mild atypia (cellular abnormalities in appearance) as pleomorphism (different shapes &amp; sizes) and hyperchromasia (increased nuclear colour)</li>
                                <li class="list-item">Increased mitosis</li>
                                <li class="list-item">Dysplasia may be low grade or high grade depending on the degree of cellular atypia.
                                    <ul class="enhanced-list">
                                        <li>Low grade dysplasia affects the basal third of the epithelium.</li>
                                        <li>High grade dysplasia affects the lower two-thirds up to the whole thickness.</li>
                                    </ul>
                                </li>
                            </ol>
                            
                            <p><strong>Prognosis &amp; clinical significance:</strong> low grade dysplasia is commonly reversible when the irritating cause is removed. High grade dysplasia and carcinoma in situ (intra epithelial malignancy not invading the basement membrane) are difficult to differentiate from one another microscopically, hence are grouped together and considered as a pre-invasive phase of malignancy</p>

                            <aside class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <span class="callout-title">N.B.</span>
                                </div>
                                <div class="callout-content">
                                    <p>Dysplasia literally means any abnormal growth. Therefore the term is sometimes used to describe certain congenital defects, such as fibrous dysplasia of bone and renal dysplasia. These types of dysplasia are not related to the conventional epithelial dysplasia described above.</p>
                                </div>
                            </aside>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-a8394693.jpeg" alt="High grade dysplasia/CIS" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 17 High grade dysplasia/CIS</figcaption>
                            </figure>
                        </div>

                        <div class="content-card">
                            <h3 id="carcinoma-in-situ">CARCINOMA IN SITU</h3>
                            <p>(Intraepithelial Neoplasia, Intraepithelial Carcinoma, Pre-invasive Carcinoma)</p>
                            
                            <p><strong>Definition:</strong> Carcinoma in situ (CIS) represents a pre-invasive stage of cancer &amp; is characterized by severe epithelial atypia (severe dysplasia) without invasion of the basement membrane. CIS is essentially a microscopic change. Once the basement membrane is invaded the CIS phase ends and actual malignant tumor starts.</p>

                            <p><strong>Pathological Features:</strong></p>
                            <p><strong>Gross features:</strong></p>
                            <ul class="enhanced-list">
                                <li class="list-item">CIS may be difficult to detect grossly.</li>
                                <li class="list-item">However some cases may cause a thick indurated patch (as CIS of cervix or bladder).</li>
                                <li class="list-item">Rarely CIS may cause a mass as in cases of CIS of mammary ducts.</li>
                            </ul>

                            <p><strong>Microscopic features:</strong> CIS is essentially a microscopic change characterized by:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">Diffuse cellular atypia involving the whole thickness of the affected epithelium. The cells are pleomorphic with dark nuclei and numerous mitoses i.e. cytologically malignant. Their architectural orientation (polarity) is disturbed.</li>
                                <li class="list-item">No invasion of basement membrane.</li>
                            </ul>

                            <p><strong>Fate:</strong> Progression into invasive carcinoma occurs after a variable time (usually years).</p>

                            <p><strong>Examples of common sites of CIS:</strong></p>
                            <ol class="enhanced-list">
                                <li class="list-item">Bladder</li>
                                <li class="list-item">Cervix &amp; endometrium</li>
                                <li class="list-item">GIT</li>
                                <li class="list-item">Mammary gland</li>
                                <li class="list-item">Skin</li>
                            </ol>
                        </div>
                    </section>
                    <!-- END: growth-disturbances -->

                    <!-- START: neoplasia -->
                    <section id="neoplasia" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">NEOPLASIA</h2>
                        </div>
                        
                        <div class="content-card">
                            <p><strong>DEFINITION:</strong> A neoplasm (tumor) is a new growth forming an abnormal mass, caused by autonomous self controlling proliferation of cells. It is characterized by being a pathologic proliferation of any cell type which is Irreversible, uncontrolled, unlimited, progressive &amp; purposeless.</p>
                            <p>The study of tumors is referred to as oncology.</p>

                            <h3 id="aetiological-aspects">AEIIOLOGICAL ASPECTS OF NEOPLASIA</h3>
                            
                            <h4 id="predisposing-factors">A) PREDISPOSING FACTORS: Co-carcinogens &amp; Precancerous factors:</h4>
                            <p>These are nonspecific promoting or helping factors which may transform the latent tumour cells to frank malignant cells.</p>
                            <ol class="enhanced-list">
                                <li class="list-item"><strong>Aging</strong> increases the risk of some types of cancer (prolonged exposure to carcinogens), e.g prostatic cancer is almost present in every male above the age of 100 years..</li>
                                <li class="list-item"><strong>Sex:</strong> Males are generally more susceptible to cancer, however some carcinomas predominate in females as breast carcinoma (very rare in males) &amp; thyroid carcinoma.</li>
                                <li class="list-item"><strong>Diet:</strong> Diet rich in fat is related to colorectal cancer, while smoked fish is related to gastric cancer.</li>
                                <li class="list-item"><strong>Environmental Factors:</strong> e.g air pollution (lung cancer), farmers (skin cancer due to prolonged exposure to sun).</li>
                                <li class="list-item"><strong>Trauma:</strong> It may be related to some types of cancer as osteosarcoma.</li>
                                <li class="list-item"><strong>Histocomaptibility type &amp; blood group:</strong> e.g gastric carcinoma is more common in blood group A persons.</li>
                                <li class="list-item"><strong>Hormonal/sex factors:</strong> $\uparrow$ oestrogen is responsible for breast cancer or uterine cancer $\uparrow$ testosterone is responsible for prostate cancer</li>
                                <li class="list-item"><strong>Chronic irritation</strong> at sites where cells are known to divide rapidly(labile) &amp; Chronic diseases (PRECANCEROUS FACTORS) Examples include:
                                    <ul class="enhanced-list">
                                        <li>Chronic Inflammatory Diseases as: a-Bilharziasis of the urinary bladder. b-Ulcerative colitis. c -Atrophic gastritis d-Radiodermatitis e-Peptic ulcer of the stomach. f-Tertiary syphilis of tongue -Lupus vulgaris (cutaneous T.B)</li>
                                        <li>Gall stones and urinary stones</li>
                                        <li>Hyperplastic and metaplastic lesions as leukoplakia, endometrial hyperplasia, mammary hyperplasia.</li>
                                        <li>Some Benign Tumors e.g villous bladder papilloma, adenomatous polyps, some nevi. .. etc</li>
                                        <li>Others as liver cirrhosis, varicose ulcers, Paget's disease of bone, undescended testis.</li>
                                    </ul>
                                </li>
                                <li class="list-item"><strong>Trauma</strong> Unknown effect but is suspected to play a role.</li>
                            </ol>

                            <h4 id="agents-causing-cancer">B) AGENTS CAUSING CANCER: Carcinogens &amp; Oncogenes</h4>
                            <p>The process of neoplasia begins with cell transformation (DNA damage &amp; genetic mutation). A variety of a) chemical carcinogens as benzene, cigarette smoke &amp; nitrites can initiate &amp; or promote this process b) Radiation, either as low level, long-term environmental gamma rays or as higher, therapeutic irradiation, can also produce genetic mutations. c) Infections particularly viral e.g. human papilloma virus (HPV) are also important agents ( $\mathrm{a} \&amp; \mathrm{~b} \&amp; \mathrm{c}$ are called carcinogens. They are external agents that can cause DNA damage ${ }^{\mathbf{1}}$ )</p>
                            
                            <aside class="callout callout--note">
                                <p>1 Examples: c-erb-B2 in breast carcinoma, ras found in many carcinomas &amp; leukemias, BRCA-1 in breast &amp; ovarian carcinomas, Rb in retinoblastoma &amp; mutations in p53 gene in many carcinomas</p>
                            </aside>

                            <p>Genetic damage with DNA alterations leads to a) point mutations, b) translocation of genetic material from one chromosome to another, c) gene reduplication with amplification. These alterations transform proto-oncogenes (genes which are responsible for promotion &amp; regulation of growth in embryogenesis or normal growth but are suppressed or "turned off' in adult life) into oncogenes (are "turned on" or activated proto-oncogenes).</p>

                            <h5 id="important-definitions">Important definitions</h5>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>a- Carcinogen:</strong> external agents, which can cause DNA damage &amp; point mutations. Carcinogens are also called teratogens if they produce neoplasia during pregnancy.</li>
                                <li class="list-item"><strong>b-Proto-oncogenes:</strong> Are normal genes that promote &amp; regulate growth i.e. expressing growth factors e.g. EGF -PDGF .... etc ... and may become mutated or activated into an oncogene. These protooncogenes are inhibited or regulated during normal growth by anti - oncogenes</li>
                                <li class="list-item"><strong>c- Anti-oncogenes</strong> which are like proto-oncogenes but express growth inhibitory effects e.g. TGF B &amp; P53, &amp; are also called tumor suppressor factors.</li>
                                <li class="list-item"><strong>d- Oncogene:</strong> is a suppressed anti-oncogene or an activated proto-oncogene (activated by change in gene structure or in gene expression i.e. functions) They are no longer sensitive to growth regulatory stimuli e.g. c- oncogene or cellular oncogene &amp; v-oncogene or viral oncogene. An oncogene can be considered as a cancer inducing gene.</li>
                            </ul>

                            <h5 id="types-of-carcinogens">TYPES OF CARCINOGENS</h5>
                            <ol class="enhanced-list">
                                <li class="list-item"><strong>CHEMICAL CARCINOGENS</strong> e.g. Aromatic hydrocarbons as 3,4 benzpyrene (exist in cigarette smoke) $\rightarrow$ cancer lung and bacterial metabolites (as nitrosamines) $\rightarrow$ cause cancer stomach.</li>
                                <li class="list-item"><strong>PHYSICAL CARCINOGENS:</strong> e.g polonged exposure to ultraviolet rays (sun ) can cause skin malignancy (basal cell carcinoma, squamous cell carcinoma &amp; melanoma).</li>
                                <li class="list-item"><strong>VIRUSES:</strong> Some viruses are oncogenic, e.g.
                                    <ul class="enhanced-list">
                                        <li>Hepatitis C or B virus $\rightarrow$ liver cancer</li>
                                        <li>Ebstein Barr virus $\rightarrow$ nasopharyngeal carcinoma and Burkitt's lymphoma</li>
                                        <li>Human papilloma virus $\rightarrow$ carcinoma of oral mucosa and cervix</li>
                                    </ul>
                                </li>
                                <li class="list-item"><strong>HORMONES:</strong> They cannot cause tumor initiation but may act as promotors. Examples include
                                    <ul class="enhanced-list">
                                        <li>Oestrogen : High levels of oestrogen can promote endometrial carcinoma &amp; mammary carcinoma.</li>
                                        <li>Androgens: Androgen in high levels can promote prostatic carcinoma.</li>
                                    </ul>
                                </li>
                            </ol>

                            <h4 id="theories-of-origin">C) THEORIES OF ORIGIN</h4>
                            <p>Most tumors arise from a single clone of cells (monoclonal), in response to an unknown or less commonly known stimulus. Several theories have been put forward:</p>
                            
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Multistep theory:</strong>
                                    <ol class="enhanced-list">
                                        <li>Stage of initiation---Exposure to carcinogen is followed by a latent stage where the affected cell remains dormant until it is acted upon by a carcinogen or non carcinogen(cocarcinogen).</li>
                                        <li>Stage of promotion-carcinogen/non carcinogen (co-carcinogen) affect latent cell which proliferates by REVERSIBLE (hyperplasia-metaplasia -dysplasia) then IRREVERSIBLE (neoplasia) growths</li>
                                        <li>Stage of neoplastic transformation/progression: Purposeless- uncontrolledprogressive cell proliferation IRREVERSIBLE</li>
                                    </ol>
                                </li>
                                <li class="list-item"><strong>Genetic mutation theory:</strong> successive DNA mutations in a single cell cause cancer (somatic mutation theory)</li>
                                <li class="list-item"><strong>Failure of immune surveillance:</strong> Failure of immune surveillance prevents removal of the new abnormal tumour cells which form during life. These cells if left in the body proliferate resulting in a neoplasm Failure of immune surveillance mechanisms: Neoplastic cells produce new or new oncoproteins or antigens (tumor associated antigens-TAA, which are considered foreign by the immune system. The immune system reacts by a cytotoxic immune response. If the immune system is defective or fails to recognize the new antigens as foreign, the cell escapes immune system &amp; a tumor is formed e.g. AIDS failure of immune system to recognize these new foreign antigens &amp; kill the cells carrying them results in tumor formation</li>
                                <li class="list-item"><strong>Inhibition of apoptosis:</strong> it is now clear that some oncogenic mutations disrupt apoptosis, leading to tumor initiation, progression or metastasis</li>
                                <li class="list-item"><strong>Virogene-oncogene theory:</strong> Viruses may lead to development of cancer by: integrating viral oncogenes into host DNA producing proteins that inactivate products made by tumour suppressor genes. Some viruses that have been implicated in causing neoplasms:
                                    <ul class="enhanced-list">
                                        <li>Epstein-Barr virus e.g. a. Burkitt's lymphoma b. form of lymphoma derived from B cells) c. Nasopharyngeal carcinoma d. other B cell lymphomas and some cases of Hodgkin's disease</li>
                                        <li>Hepatitis B causes hepato cellular carcinoma</li>
                                        <li>Human papillomavirus causes cervical carcinoma and some forms of carcinoma of skin cancers</li>
                                        <li>HTLV-1 causes T ceilleukaemia/lymphoma</li>
                                    </ul>
                                </li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: neoplasia -->

                    <!-- START: characteristics -->
                    <section id="characteristics" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">GENERAL CHARACTERISTICS OF TUMORS</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>A) Structural<br>
                            B) Behavioral including complications &amp; spread as well as causes of death</p>
                            <p>All tumours share certain structural &amp; behavioral features, such as:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">Tumor proliferation is due to genetic abnormalities (inherited or acquired).</li>
                                <li class="list-item">Tumor proliferation does not respect the rules that control normal cell growth, e.g.:
                                    <ol class="enhanced-list">
                                        <li>Tumors can be derived from any cells, even from permanent cells that do not normally divide (nerve cells and striated muscle cells).</li>
                                        <li>Cell proliferation is irreversible and unlimited. Thus cell proliferation progresses even after Any tumor consists of proliferating cells and fibrovascular stroma.</li>
                                    </ol>
                                </li>
                            </ul>
                            
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>HYPERPLASIA</th>
                                                <th>NEOPLASIA</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>- Excited by a stimulus</td>
                                                <td>- A stimulus is not always detected.</td>
                                            </tr>
                                            <tr>
                                                <td>- Reversible, i.e. pathological hyperplasia stops and disappears if the stimulus abates.</td>
                                                <td>- Irreversible, i.e. cell proliferation is unlimited and progresses independent of any stimuli.</td>
                                            </tr>
                                            <tr>
                                                <td>- Proliferated cells are normal-shaped</td>
                                                <td>- Proliferated cells in case of malignant neoplasia are abnormal-shaped.</td>
                                            </tr>
                                            <tr>
                                                <td>- May be useful (e.g. compensatory hyperplasia)</td>
                                                <td>- Harmful</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <p>According to their behavior, tumors are classified into:</p>
                            <p><strong>A. According to type of growth (Benign or malignant) Plate 9</strong></p>
                            <ul>
                                <li>Malignant tumours are further subdivided into: Insitu Intraepithelial and Invasive - There are 2 main types of invasive tumours:
                                    <ul class="enhanced-list">
                                        <li>Locally malignant No metastasis and $\longleftrightarrow$ frank Invasive with metastasis</li>
                                    </ul>
                                </li>
                            </ul>
                            <p>N.B.: Invasive tumours are called:<br>
                            a) Primary: original single tumour mass<br>
                            b) Occult: Hidden primary<br>
                            c) Secondaries (metastasis): spread, many masses.</p>

                            <p><strong>B) According to histological origin of tumour (epithelial, mesenchymal or other)</strong></p>

                            <div class="topics-grid">
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251212-72c6c0a0.jpeg" alt="Benign tumour (lipoma)" class="figure-image">
                                    </div>
                                    <figcaption class="figure-caption">Benign tumour (lipoma)</figcaption>
                                </figure>
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251212-a225b23d.jpeg" alt="Benign tumour (chondroma)" class="figure-image">
                                    </div>
                                    <figcaption class="figure-caption">Benign tumour (chondroma)</figcaption>
                                </figure>
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251212-bb63128f.jpeg" alt="Malignant tumour (Osteosarcoma)" class="figure-image">
                                    </div>
                                    <figcaption class="figure-caption">Malignant tumour (Osteosarcoma)</figcaption>
                                </figure>
                            </div>

                            <h3 id="classification-histological">Classification</h3>
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Tissue of Origin</th>
                                                <th>Benign</th>
                                                <th>Malignant</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>A) EPITHELIUM:</td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>1. SURFACE EPITHELIUM.</td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>a) Stratiffed squamous</td>
                                                <td>Squamous cell papilloma</td>
                                                <td>Squamous cell carcinoma</td>
                                            </tr>
                                            <tr>
                                                <td>b) Transilional</td>
                                                <td>Transilional cell papilloma</td>
                                                <td>Transilional cell carcinoma</td>
                                            </tr>
                                            <tr>
                                                <td>c) Ducts of glands</td>
                                                <td>Duct papilloma</td>
                                                <td>Duct carcinoma</td>
                                            </tr>
                                            <tr>
                                                <td>d) Mucosa of GIT</td>
                                                <td>Adenomalous polyp</td>
                                                <td>Adenocarcinoma</td>
                                            </tr>
                                            <tr>
                                                <td>2. GLANDULAR EPITHELIUM</td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Endocrine &amp; Exocrine glands</td>
                                                <td>Adenoma</td>
                                                <td>Adenocarcinoma</td>
                                            </tr>
                                            <tr>
                                                <td>B) MESENCHYME</td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>1- CONNECTIVE TISSUE</td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>a) Fibrous</td>
                                                <td>Fibroma</td>
                                                <td>Fibrosarcoma</td>
                                            </tr>
                                            <tr>
                                                <td>b) Adipose</td>
                                                <td>Lipoma</td>
                                                <td>Liposarcoma</td>
                                            </tr>
                                            <tr>
                                                <td>c) Primitive mesenchyme</td>
                                                <td>Myxoma</td>
                                                <td>?Myxosarcoma</td>
                                            </tr>
                                            <tr>
                                                <td>d) Bone</td>
                                                <td>Osleoma &amp; osleoblasloma</td>
                                                <td>Osteosarcoma.</td>
                                            </tr>
                                            <tr>
                                                <td>e) Cartilage</td>
                                                <td>Chondroma, osteochondroma</td>
                                                <td>Chondrosarcoma</td>
                                            </tr>
                                            <tr>
                                                <td>2- SMOOTH MUSCLE</td>
                                                <td>Leiomyoma</td>
                                                <td>Leiomyosarcoma</td>
                                            </tr>
                                            <tr>
                                                <td>3- STRIATED MUSCLE</td>
                                                <td>Rhabdomyoma</td>
                                                <td>Rhabdomyosarcoma</td>
                                            </tr>
                                            <tr>
                                                <td>4- ENDOTHELIUM</td>
                                                <td>Angioma</td>
                                                <td>Angiosarcoma</td>
                                            </tr>
                                            <tr>
                                                <td>5- MESOTHELIUM</td>
                                                <td>Rare</td>
                                                <td>Mesothelioma</td>
                                            </tr>
                                            <tr>
                                                <td>6- Synovium</td>
                                                <td></td>
                                                <td>Synovial sarcoma</td>
                                            </tr>
                                            <tr>
                                                <td>C) OTHERS</td>
                                                <td></td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>1- Pigmenled cells</td>
                                                <td>Nevus (benign melanoma)</td>
                                                <td>Malignant melanoma</td>
                                            </tr>
                                            <tr>
                                                <td>2- Totipotent cells</td>
                                                <td>Teratoma ,malure (benign)</td>
                                                <td>Terafoma,immalure (malign)</td>
                                            </tr>
                                            <tr>
                                                <td>3- Embryonic cells</td>
                                                <td></td>
                                                <td>Embryonic rumors</td>
                                            </tr>
                                            <tr>
                                                <td>4- Lymphoid &amp; hemopoeitic</td>
                                                <td></td>
                                                <td>Lymphoma &amp; leukemia</td>
                                            </tr>
                                            <tr>
                                                <td>5- Schwann cells</td>
                                                <td>Schwannoma</td>
                                                <td>Malignant schwannoma</td>
                                            </tr>
                                            <tr>
                                                <td>6- Trophoblast</td>
                                                <td>Vesicular mole</td>
                                                <td>Choriocarcinoma</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                            
                            <h3 id="benign-vs-malignant">CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS (BR)</h3>
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>BENIGN NEOPLASMS</th>
                                                <th>MALIGNANT NEOPLASMS</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>A. TUMOR STRUCTURE</strong> <br> 1-GROSS FEATURES: <br> Regular defined tumor <br> - In solid organs the tumor appears lobular and commonly capsulated <br> - Tumors arising from a surface (skin, &amp; mucous membranes) appear as a defined noncapsulated projection called papilloma</td>
                                                <td><strong>A. TUMOR STRUCTURE</strong> <br> 1-GROSS FEATURES: <br> Irregular ill-defined noncapsulated tumor with the cut section of the tumor often showing areas of Hge &amp; necrosis. <br> - A tumor inside a solid organ appears as an irregular mass. <br> - Tumors arising from surface epithelia appear are either: <br> 1- Polypoid fungating cauliflower mass <br> 2- Ulcerative pattern: with raised everted edges, rough necrotic floor <br> $\&$ <br> indurated base, <br> 3- Irregular infiltrative growth below the surface.</td>
                                            </tr>
                                            <tr>
                                                <td>2-MICROSCOPIC FEATURES: <br> a)Cell Differentiation: Excellent The cells are perfectly differentiated i.e. closely mimic the corresponding normal cells. Rare mitoses.</td>
                                                <td>2-MICROSCOPIC FEATURES: <br> a)Cellular Anaplasia (bad differentiation): <br> 1) Cellular pleomorphism. <br> 2) Nuclear pleomorphism: <br> 3)High N/C ratio and hyperchromatism <br> 4) Nucleoli may be prominent. <br> 5) Abundant mitoses <br> 6)Tumor giant cells containing a singleLarge <br> polypoid nucleus or multiple nuclei</td>
                                            </tr>
                                            <tr>
                                                <td>b)Structural (histological) Differentiation: <br> This is the degree of resemblance of the structural pattern of the tumor to that of the normal tissue In benign tumors the tumor cells exhibit structural patterns similar to the normal tissue (perfectly differentiated</td>
                                                <td>b)Histological Differentiation: . <br> May be graded as well differentiated (grade I), moderately differentiated (grade II), poorly differentiated (grade III) &amp; undifferentiated (grade IV), according to the degree of differentiation</td>
                                            </tr>
                                            <tr>
                                                <td><strong>B. TUMOR BEHAVIOR</strong> <br> 1-Rate of Growth: Often slow. <br> 2-Mode of Growth: Expansile, compressing without invasion <br> 3- Prognosis: <br> a. Benign tumors do not spread <br> b. Benign tumors do not recur if well excised. <br> c. Benign tumors are not dangerous unless: <br> - They arise in vital organs as brain. <br> - They cause obstruction. <br> - They produce hormones <br> - They may change malignant</td>
                                                <td><strong>B. TUMOR BEHAVIOR</strong> <br> 1- Rate of Growth: Often rapid. <br> 2- Mode of growth: Invasive <br> 3- Prognosis: <br> a. Malignant tumors spread (local &amp; distant). <br> b. Recurrence is very common <br> c. Malignant tumors are serious &amp; cause death due to spread, cachexia, infections &amp; organ destruction &amp; failure (e.g. liver failure, respiratory failure, renal failure ... ) <br> d. Some malignant tumours may act as functioning tumours e.g. <br> - Endocrinal tumour may over secrete FUNCTIONING tumour. <br> - Non endocrinal ECTOPIC hormone or polypeptide production (e.g. Lung cancer may produce ACTH &amp; Cushing syndrome. Such non endocrinal tumours which produce signs and symptoms of a known endocrinal disorder are termed paraneoplastic syndromes. <br> e. Complications of any malignancy <br> - General complications: <br> 1. Cachexia 2. Anemia 3. Hemorrhages <br> 4- Severe infection <br> - Local complications of any malignancy: Organ failure due to destruction- Obstruction - Pressure <br> - Complications due to spread of tumour: <br> 1- Lymphatic spread <br> 2- Blood stream spread <br> 3- Transceolomic:Krukenberg T ovary <br> 4- Implantation <br> a) Transcanalicular <br> b) Direct implantation or inoculation</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: characteristics -->
                    
                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="topic-07-circulatory-disturbances.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Circulatory Dist.</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="topic-08-neoplasia-part2.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Neoplasia Pt.2</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>